I-Inositol ibonisa isithembiso njengendlela yokwelashwa okuyisisekelo kubo bonke abesifazane abane-PCOS ngenxa yokukwazi kwayo ukuthuthukisa izici zokuxilonga nokuzala. Nakhu okumele ukwazi.
I-Inositols Yizigijimi Zesibili
Ama-inositols afana ne- myo ne-d-chiro inositol (DCI), angamalungu amavithamini B nesakhi sekhanda leseli. I-inositol itholakala ekudleni okufana nezithelo , ubhontshisi, okusanhlamvu, namantongomane futhi yenziwa nomzimba.
I-Myo ne-DCI basebenza njengabathunywa be-secondary behambisa izimpawu ezihileleke ekulawulweni kwe-insulin. Kukholelwa ukuthi abesifazane abane-PCOS bangase babe nephutha emandleni omzimba wokuguqula i-MYO ku-DCI, okufaka isandla ekukhuseni kwe- insulin nokungabi namandla. Ukwengeza nge-inositol kubekezelela kahle (akukho nemiphumela emibi ye-GI njengo-metformin) futhi kuboniswe ukuthuthukisa amazinga e-insulin nokunciphisa ukufisa okukhulu.
Ukuhlanganiswa komsebenzi weMyo noD-Chiro Best
Ucwaningo olusha olwenziwe ngemiphumela ye-inositol luye lwaveza ukuthi iningi lamathambo emzimbeni anesilinganiso se-myo ku-DCI ka-40: 1. Ukuthatha inhlanganisela yalezi zithako ezimbili kule isilinganiso kunokuba nje uthathe i-myo noma i-DCI yedwa, kunconywa.
Uma kuqhathaniswa ne-myo inositol, inhlanganisela ye-myo kuya ku-DCI ibonise izinzuzo ezengeziwe zokuthuthukisa imingcele ye-metabolic (ukwehlisa i-insulini, i-cholesterol, nezimpawu zokuvuvukala ) kwabesifazane abane-PCOS.
Uma kuqhathaniswa ne- metformin , inhlanganisela ye-myo ne-DCI ku-40: 1 isilinganiso yabonisa imiphumela engcono kakhulu ngokuphathelene nokulahlekelwa isisindo, ukuvota nokukhulelwa (46.7 vs.11.2%).
I-Inositol Ratio ithinta i-Quality Quality kanye nokuzala
Ukungalingani emkhatsini womzimba womzimba we-myo kuya ku-DCI isilinganiso kungathinta izinga leqanda. I-Myo inositol iboniswe ukuthuthukisa ikhwalithi yeqanda kulabafazi abane-PCOS kanti i-DCI ephathwe ngamasethingi aphezulu (600-2400 mg nsuku zonke) itholakala ukuthi iyithinte kabi izinga le-oocyte kanye nempendulo ye-ovarian.
Ngaphezu kwalokho, izinga eliphakeme le-DCI (futhi lingalinganisani isilinganiso se-MYO kuya ku-DCI), izinga elibi kakhulu le-oocyte kanye nokuphendula kwe-ovarian.
I-Inositol May Yinciphise Umngcipheko We-Gestational Diabetes
Kuphakanyisiwe ukuthi abesifazane abane-PCOS bangase babe nengozini yokwanda yesifo sikashukela sokukhulelwa (GDM) ekukhulelwe. Ucwaningo luye lwabonisa ukuthi ukugcwalisa i-myo inositol phakathi nokukhulelwa kuyasebenza ekunciphiseni ingozi ye-GDM kwabesifazane abakhuluphele kakhulu nabesifazane abane-PCOS. Ucwaningo lwe- Gynecology Endocrinology lubonise ukusabalala kweGDM phakathi kwabesifazane abakhulelwe nge-PCOS abayithatha i-myo-inositol iqembu laliyi-17.4% ngokumelene no-54% eqenjini lokulawula.
Imithombo
UHamid A et al. I-Health-based Based Women's Journal Journal. 2015; 5 (3): 93-98.
D'Anna R1, Di Benedetto V, Rizzo P, Raffone E, Interdonato ML, Corrado F, Di Benedetto A. I-Myo-inositol ingavimbela isifo sikashukela sokubeletha kubesifazane be-PCOS. I-Gynecol Endocrinol. 2012 Jun; 28 (6): 440-2.
I-Costantino D, i-Minozzi G, i-Minozzi E, i-Guaraldi C. I-Metabolic nemiphumela ye-hormone ye-myo-inositol kwabesifazane abane-polycystic ovary syndrome: isilingo se-doubleblind. Ukubuyekeza kwe-Europ med pharolol sci. 2009; 13 (2): 105-110.
Unfer V, Carlomagno G, Rizzo P, Raffone E, uRoseff S. Myo-inositol esikhundleni seD-chiro-inositol uyakwazi ukuthuthukisa ikhwalithi ye-oocyte emjikelezweni wokujola umuthi we-intracytoplasmic. Isivivinyo esibheke, esilawulwayo, esihleliwe. Ukubuyekeza kwe-Europ med pharolol sci. 2011; 15 (4): 452-457.
Le Donne M, Alibrandi A, Giarrusso R, Lo Monaco I, Muraca U. [Ukudla, i-metformin ne-inositol ekuqhathaniseni ngokweqile futhi kunzima kakhulu abesifazane abane-polycystic ovary syndrome: imiphumela ekubunjweni komzimba]. Minerva ginecologica. 2012; 64 (1): 23-29.
I-Venturella R, Mocciaro R, De Trana E, D'Alessandro P, Morelli M, Zullo F. [Ukuhlolwa kokuguqulwa kwendlela yokuthola imitholampilo, ye-endocrinal kanye ne-metabolical yeziguli ezine-PCOS syndrome ephathwa nge-myo-inositol]. Minerva ginecologica. 2012; 64 (3): 239-243.
Genazzani AD, Prati A, Santagni S, et al. Ukusabela okuhlukile kwe-insulin ekulawulweni kwe-myo-inositol ezigulini ze-polycystic ovary syndrome ezikhulu kakhulu. I-Gynecol Endocrinol. 2012; 28 (12): 969-973.
UGerli S, uPapaleo E, uFerrari A, uDi Renzo GC. I-Randomized, ivivinyo elilawulwa yi-placebo eliyimpumputhe eliphindwe kabili: imiphumela ye-myo-inositol emisebenzini ye-ovarian kanye nezici ze-metabolic kwabesifazane abane-PCOS. I-Europ rev med pharmacol sci. 2007; 11 (5): 347-354.
I-Raffone E, i-Rizzo P, i-Benedetto V. I-insulin i-agent ezwayo yodwa kanye ne-co-treatment ne-r-FSH yokufakelwa kwe-ovulation kuma-PCOS abesifazane. I-Gynecol Endocrinol. 2010; 26 (4): 275-280.
I-Galazis N, i-Galazi M, i-Atiomo W. d-Chiro-inositol nokubaluleka kwayo kwi-polycystic ovary syndrome: ukubuyekezwa okuhlelekile. I-Gynecol Endocrinol. 2011; 27 (4): 256-62
Papaleo, E., Unfer, V., iBaillargeon, JP, et al. (2007). I-Myo-inositol kweziguli ezine-polycystic ovary syndrome: Indlela yenombono yokufakelwa kwe-ovulation. Endrocrinology ye-Gynecological, 23 (12): 700-703.
D 'Anna R, Di Benedetto V, Rizzo P, et al. I-Myo-inositol ingavimbela isifo sikashukela sokugaya emakhayeni ase-PCOS. I-Gynecol Endocrinol. 2012; 28 (6): 440-442.
U-Isabella R, uRaffone E. Ingabe i-ovary idinga i-D-chiro-inositol? J Ovarian Res. 2012 Meyi 15; 5 (1): 14.
I-Dinicola S1, i-Chiu TT, i-Unfer V, iCarlomagno G, i-Bizzarri M. Isizathu se-myo-inositol no-D-chiro-inositol ukwelashwa okuhlangene kwe-polycystic ovariary syndrome. J Clin Pharmacol. 2014 Oct; 54 (10): 1079-92.
I-Nordio M, i-Proietti E. Ukwelapha okuhlangene ne-myo-inositol kanye ne-D-chiro-inositol kunciphisa ingozi yezifo zamangqamuzana ku-PCOS iziguli ezinamandla kakhulu uma kuqhathaniswa ne-myo-inositol supplementation yedwa. I-Eur Rev Med Pharmacol Sci. 2012 Meyi; 16 (5): 575-81.
Colazingari S, Treglia M, Najjar R, Bevilacqua A. Ukwelashwa okuhlangene myo-inositol kanye no-D-chiro-inositol, kunokuba uD-chiro-inositol, ukwazi ukuthuthukisa imiphumela ye-IVF: imiphumela evela ekuhlolweni okulawulwa ngokungahleliwe. I-Arch Gynecol Obstet. 2013 Dec; 288 (6): 1405-11.